Farms, Animals and Adolescents: Reinforcing the Microbiome
NCT ID: NCT03189849
Last Updated: 2017-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
11 participants
OBSERVATIONAL
2017-05-10
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to attend camp at Heartland Farm Sanctuary for either 1, 2, or 3 consecutive weeks (if not consecutive, but within a 4-week period, this is allowable)
* In generally good health
* Have not taken antibiotics in the four weeks prior to when their first baseline set of samples will be collected
* Have not attended camp at HFS or regular volunteer activities at HFS in the past year (participation in previous summer HFS camp is permissible)
* Able to understand the nature of the study and able to provide assent
* Able to communicate in English with study personnel.
* Willing to commit to participating in the study and doing the home collection of samples.
* Parent or legal guardian of a child attending HFS summer camp and participating in this study
* Willing to assist the child in the collection of samples as necessary
* Willing to answer questionnaire about their child's participation in the study
* Able to communicate in English with study personnel
Exclusion Criteria
* Plan to attend camp during the fall (i.e. during their month 1 month follow-up)
* Children living in farming environments prior to camp participation
* Children with more than an average of one exposure per week to farm animals, livestock, horses
* Individuals currently on any antibiotic therapy or who will require chronic and/or periodic antibiotic treatment during the study period.
* Subject has a medical condition or disorder that
* Is unstable, or:
* Could interfere with the accurate assessment of safety or efficacy of the clinical assessments, including individuals with any:
* Current participation in any clinical trial that might impact results of this one, which includes participation in another clinical trial where any experimental drugs are being taken as well as studies / drug trials with agents that might affect mood and or the gastrointestinal tract.
* Reasonable likelihood for non-compliance with the protocol for any other reason, in the opinion of the Investigator, prohibits enrollment of subject into the study.
* Unwilling to assist their child in collection of the samples for this study
* Unwilling to answer questionnaire about their child's participation in the study
* Unable to communicate in English with study personnel
7 Years
13 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin-Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-0154
Identifier Type: -
Identifier Source: org_study_id